Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             122 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Activation of complement by therapeutic liposomes and other lipid excipient-based therapeutic products: Prediction and prevention Szebeni, Janos
 2011
 110-111 12 p. 1020-1030
11 p.
 artikel
2 Advances in assay of complement function and activation Harboe, Morten
 2011
 110-111 12 p. 976-987
12 p.
 artikel
3 Advances in the development of new therapeutic agents targeting the NS3-4A serine protease or the NS5B RNA-dependent RNA polymerase of the hepatitis C virus De Francesco, Raffaele
 2007
 110-111 12 p. 1242-1262
21 p.
 artikel
4 Aβ immunization and anti-Aβ antibodies: potential therapies for the prevention and treatment of Alzheimer’s disease Holtzman, David M
 2002
 110-111 12 p. 1603-1613
11 p.
 artikel
5 Alpha-particles for targeted therapy Sgouros, George
 2008
 110-111 12 p. 1402-1406
5 p.
 artikel
6 Amyloidosis and Alzheimer’s disease Ghiso, Jorge
 2002
 110-111 12 p. 1539-1551
13 p.
 artikel
7 A new in vitro model for blood–cerebrospinal fluid barrier transport studies: an immortalized choroid plexus epithelial cell line derived from the tsA58 SV40 large T-antigen gene transgenic rat Hosoya, Ken-ichi
 2004
 110-111 12 p. 1875-1885
11 p.
 artikel
8 Announcement 2003
 110-111 12 p. I-II
nvt p.
 artikel
9 Antibody tumor penetration: Transport opposed by systemic and antigen-mediated clearance Thurber, Greg M.
 2008
 110-111 12 p. 1421-1434
14 p.
 artikel
10 Atelocollagen for protein and gene delivery Sano, Akihiko
 2003
 110-111 12 p. 1651-1677
27 p.
 artikel
11 Bifunctional coupling agents for radiolabeling of biomolecules and target-specific delivery of metallic radionuclides Liu, Shuang
 2008
 110-111 12 p. 1347-1370
24 p.
 artikel
12 Biomaterial delivery of morphogens to mimic the natural healing cascade in bone Mehta, Manav
 2012
 110-111 12 p. 1257-1276
20 p.
 artikel
13 Biomimetic hydrogels for controlled biomolecule delivery to augment bone regeneration Lienemann, Philipp S.
 2012
 110-111 12 p. 1078-1089
12 p.
 artikel
14 Bone repair cells for craniofacial regeneration Pagni, G.
 2012
 110-111 12 p. 1310-1319
10 p.
 artikel
15 Calcium phosphate cements as drug delivery materials Ginebra, Maria-Pau
 2012
 110-111 12 p. 1090-1110
21 p.
 artikel
16 Carbon nanofibers and carbon nanotubes in regenerative medicine Tran, Phong A.
 2009
 110-111 12 p. 1097-1114
18 p.
 artikel
17 Cellular phenotype switching and microvesicles Quesenberry, Peter J.
 2010
 110-111 12 p. 1141-1148
8 p.
 artikel
18 Collagen as a carrier for on-site delivery of antibacterial drugs Ruszczak, Zbigniew
 2003
 110-111 12 p. 1679-1698
20 p.
 artikel
19 Collagen gel systems for sustained delivery and tissue engineering Wallace, Donald G
 2003
 110-111 12 p. 1631-1649
19 p.
 artikel
20 Collagen in drug delivery and tissue engineering Friess, Wolfgang
 2003
 110-111 12 p. 1529-1530
2 p.
 artikel
21 Collagens—major component of the physiological cartilage matrix, major target of cartilage degeneration, major tool in cartilage repair Aigner, T
 2003
 110-111 12 p. 1569-1593
25 p.
 artikel
22 Collagen sponges for bone regeneration with rhBMP-2 Geiger, M
 2003
 110-111 12 p. 1613-1629
17 p.
 artikel
23 Collagens—structure, function, and biosynthesis Gelse, K.
 2003
 110-111 12 p. 1531-1546
16 p.
 artikel
24 Complement activation by carbon nanotubes Rybak-Smith, Malgorzata J.
 2011
 110-111 12 p. 1031-1041
11 p.
 artikel
25 Complement in health and disease Carroll, Maria V.
 2011
 110-111 12 p. 965-975
11 p.
 artikel
26 Complement monitoring of nanomedicines and implants Moghimi, S.M.
 2011
 110-111 12 p. 963-964
2 p.
 artikel
27 Confocal imaging of xenobiotic transport across the choroid plexus Miller, David S.
 2004
 110-111 12 p. 1811-1824
14 p.
 artikel
28 DDE transposases: Structural similarity and diversity Nesmelova, Irina V.
 2010
 110-111 12 p. 1187-1195
9 p.
 artikel
29 Delivery of nucleic acid therapeutics by genetically engineered hematopoietic stem cells Doering, Christopher B.
 2010
 110-111 12 p. 1204-1212
9 p.
 artikel
30 Delivery systems for the targeted radiotherapy of cancer Sofou, Stavroula
 2008
 110-111 12 p. 1317-1318
2 p.
 artikel
31 Demineralized bone matrix as a vehicle for delivering endogenous and exogenous therapeutics in bone repair Holt, Dolly J.
 2012
 110-111 12 p. 1123-1128
6 p.
 artikel
32 Demineralized bone matrix in bone repair: History and use Gruskin, Elliott
 2012
 110-111 12 p. 1063-1077
15 p.
 artikel
33 Detoxification systems, passive and specific transport for drugs at the blood–CSF barrier in normal and pathological situations Strazielle, Nathalie
 2004
 110-111 12 p. 1717-1740
24 p.
 artikel
34 Development of macromolecular prodrug for rheumatoid arthritis Yuan, Fang
 2012
 110-111 12 p. 1205-1219
15 p.
 artikel
35 Drug transfer in the choroid plexus. Multiplicity and substrate specificities of transporters Ghersi-Egea, Jean-François
 2004
 110-111 12 p. 1693-1694
2 p.
 artikel
36 Editorial Board 2010
 110-111 12 p. ii-
1 p.
 artikel
37 Editorial Board 2009
 110-111 12 p. ii-
1 p.
 artikel
38 Editorial Board 2003
 110-111 12 p. ii-
1 p.
 artikel
39 Editorial Board 2002
 110-111 12 p. ii-
1 p.
 artikel
40 Editorial Board 2004
 110-111 12 p. ii-
1 p.
 artikel
41 Editorial Board 2008
 110-111 12 p. ii-
1 p.
 artikel
42 Editorial Board 2005
 110-111 12 p. ii-
1 p.
 artikel
43 Editorial Board 2007
 110-111 12 p. ii-
1 p.
 artikel
44 Editorial Board 2012
 110-111 12 p. ii-
1 p.
 artikel
45 Editorial Board 2011
 110-111 12 p. ii-
1 p.
 artikel
46 Effect of collagen matrices on dermal wound healing Ruszczak, Zbigniew
 2003
 110-111 12 p. 1595-1611
17 p.
 artikel
47 Efflux transport systems for organic anions and cations at the blood–CSF barrier Kusuhara, Hiroyuki
 2004
 110-111 12 p. 1741-1763
23 p.
 artikel
48 Electrohydrodynamics: A facile technique to fabricate drug delivery systems Chakraborty, Syandan
 2009
 110-111 12 p. 1043-1054
12 p.
 artikel
49 Electrospinning of collagen/biopolymers for regenerative medicine and cardiovascular tissue engineering Sell, Scott A.
 2009
 110-111 12 p. 1007-1019
13 p.
 artikel
50 Electrospinning of polysaccharides for regenerative medicine Lee, Kuen Yong
 2009
 110-111 12 p. 1020-1032
13 p.
 artikel
51 Electrospun materials as potential platforms for bone tissue engineering Jang, Jun-Hyeog
 2009
 110-111 12 p. 1065-1083
19 p.
 artikel
52 Electrospun scaffolds for stem cell engineering Lim, Shawn H.
 2009
 110-111 12 p. 1084-1096
13 p.
 artikel
53 Electrospun silk biomaterial scaffolds for regenerative medicine Zhang, Xiaohui
 2009
 110-111 12 p. 988-1006
19 p.
 artikel
54 Evaluation systems for anti-HCV drugs Moriishi, Kohji
 2007
 110-111 12 p. 1213-1221
9 p.
 artikel
55 Gene delivery to bone Evans, C.H.
 2012
 110-111 12 p. 1331-1340
10 p.
 artikel
56 Gene therapy approaches to regenerating bone Kimelman Bleich, Nadav
 2012
 110-111 12 p. 1320-1330
11 p.
 artikel
57 Global regulatory registration requirements for collagen-based combination products: points to consider O'Grady, Judith E
 2003
 110-111 12 p. 1699-1721
23 p.
 artikel
58 Growth factor delivery: How surface interactions modulate release in vitro and in vivo King, William J.
 2012
 110-111 12 p. 1239-1256
18 p.
 artikel
59 Guide to Authors 2003
 110-111 12 p. 1723-1726
4 p.
 artikel
60 Guide to Authors 2002
 110-111 12 p. 1657-1659
3 p.
 artikel
61 Guide to Authors 2004
 110-111 12 p. 1887-1890
4 p.
 artikel
62 HCV research and anti-HCV drug discovery: Toward the next generation Wakita, Takaji
 2007
 110-111 12 p. 1196-1199
4 p.
 artikel
63 Hepatitis C viral life cycle Suzuki, Tetsuro
 2007
 110-111 12 p. 1200-1212
13 p.
 artikel
64 How to find effective functional monomers for effective molecularly imprinted polymers? Karim, Kal
 2005
 110-111 12 p. 1795-1808
14 p.
 artikel
65 Immobilized antibiotics to prevent orthopaedic implant infections Hickok, Noreen J.
 2012
 110-111 12 p. 1165-1176
12 p.
 artikel
66 Innate immunity activation on biomaterial surfaces: A mechanistic model and coping strategies Ekdahl, Kristina N.
 2011
 110-111 12 p. 1042-1050
9 p.
 artikel
67 Interferon-based therapy of hepatitis C Chevaliez, Stéphane
 2007
 110-111 12 p. 1222-1241
20 p.
 artikel
68 Intra-operatively customized implant coating strategies for local and controlled drug delivery to bone Trajkovski, Branko
 2012
 110-111 12 p. 1142-1151
10 p.
 artikel
69 Local delivery of nitric oxide: Targeted delivery of therapeutics to bone and connective tissues Nichols, Scott P.
 2012
 110-111 12 p. 1177-1188
12 p.
 artikel
70 Local delivery of small and large biomolecules in craniomaxillofacial bone Ji, Wei
 2012
 110-111 12 p. 1152-1164
13 p.
 artikel
71 Material properties in complement activation Moghimi, S. Moein
 2011
 110-111 12 p. 1000-1007
8 p.
 artikel
72 Mesenchymal stem cells as therapeutics and vehicles for gene and drug delivery Porada, Christopher D.
 2010
 110-111 12 p. 1156-1166
11 p.
 artikel
73 Mesenchymal stem cells for the sustained in vivo delivery of bioactive factors Meyerrose, Todd
 2010
 110-111 12 p. 1167-1174
8 p.
 artikel
74 Methods to assess stem cell lineage, fate and function Nguyen, Patricia K.
 2010
 110-111 12 p. 1175-1186
12 p.
 artikel
75 Modulation of host metabolism as a target of new antivirals Ikeda, Masanori
 2007
 110-111 12 p. 1277-1289
13 p.
 artikel
76 Molecular imprinted polymer sensors: Implications for therapeutics Hillberg, A.L.
 2005
 110-111 12 p. 1875-1889
15 p.
 artikel
77 Molecularly imprinted drug delivery systems Cunliffe, David
 2005
 110-111 12 p. 1836-1853
18 p.
 artikel
78 Molecularly imprinted polymers: A bridge to advanced drug delivery Sellergren, Börje
 2005
 110-111 12 p. 1733-1741
9 p.
 artikel
79 Molecularly imprinted polymers for the enantioseparation of chiral drugs Ansell, Richard J.
 2005
 110-111 12 p. 1809-1835
27 p.
 artikel
80 Molecularly imprinted polymers in the drug discovery process Rathbone, Daniel L.
 2005
 110-111 12 p. 1854-1874
21 p.
 artikel
81 Molecularly imprinted polymers: technology and applications Allender, Chris J.
 2005
 110-111 12 p. 1731-1732
2 p.
 artikel
82 Mood stabilizers in Alzheimer’s disease: symptomatic and neuroprotective rationales Tariot, Pierre N
 2002
 110-111 12 p. 1567-1577
11 p.
 artikel
83 Nanofiber-based delivery of bioactive agents and stem cells to bone sites Zhang, Zhanpeng
 2012
 110-111 12 p. 1129-1141
13 p.
 artikel
84 Nanofibers in regenerative medicine and drug delivery Chew, Sing Yian
 2009
 110-111 12 p. 987-
1 p.
 artikel
85 Neuroinflammation and anti-inflammatory therapy for Alzheimer’s disease Moore, Amy H
 2002
 110-111 12 p. 1627-1656
30 p.
 artikel
86 Optimization, evaluation, and characterization of molecularly imprinted polymers Spivak, David A.
 2005
 110-111 12 p. 1779-1794
16 p.
 artikel
87 Peptide and peptide analog transport systems at the blood–CSF barrier Smith, David E.
 2004
 110-111 12 p. 1765-1791
27 p.
 artikel
88 Peptide-based delivery to bone Aoki, Kazuhiro
 2012
 110-111 12 p. 1220-1238
19 p.
 artikel
89 Phage display technology for stem cell delivery and systemic therapy Staquicini, Fernanda I.
 2010
 110-111 12 p. 1213-1216
4 p.
 artikel
90 Pharmacokinetics and dosimetry of 188Re-pharmaceuticals Ferro-Flores, Guillermina
 2008
 110-111 12 p. 1389-1401
13 p.
 artikel
91 Platelets as delivery systems for disease treatments Shi, Qizhen
 2010
 110-111 12 p. 1196-1203
8 p.
 artikel
92 Potential role of ABC transporters as a detoxification system at the blood–CSF barrier de Lange, Elizabeth C.M.
 2004
 110-111 12 p. 1793-1809
17 p.
 artikel
93 Preface 2002
 110-111 12 p. 1533-1537
5 p.
 artikel
94 Principles and applicability of CSF sampling for the assessment of CNS drug delivery and pharmacodynamics Shen, Danny D.
 2004
 110-111 12 p. 1825-1857
33 p.
 artikel
95 Protein ultrastructure and the nanoscience of complement activation Vorup-Jensen, Thomas
 2011
 110-111 12 p. 1008-1019
12 p.
 artikel
96 Radionuclides delivery systems for nuclear imaging and radiotherapy of cancer Hamoudeh, Misara
 2008
 110-111 12 p. 1329-1346
18 p.
 artikel
97 Realizing the potential of the Actinium-225 radionuclide generator in targeted alpha particle therapy applications Miederer, Matthias
 2008
 110-111 12 p. 1371-1382
12 p.
 artikel
98 Receptor for advanced glycation endproducts: a multiligand receptor magnifying cell stress in diverse pathologic settings Stern, David
 2002
 110-111 12 p. 1615-1625
11 p.
 artikel
99 Recombinant collagen and gelatin for drug delivery Olsen, David
 2003
 110-111 12 p. 1547-1567
21 p.
 artikel
100 Renal uptake and metabolism of radiopharmaceuticals derived from peptides and proteins Akizawa, Hiromichi
 2008
 110-111 12 p. 1319-1328
10 p.
 artikel
101 RNA therapeutics targeting osteoclast-mediated excessive bone resorption Wang, Yuwei
 2012
 110-111 12 p. 1341-1357
17 p.
 artikel
102 β-Secretase (BACE) as a drug target for alzheimer’s disease Vassar, Robert
 2002
 110-111 12 p. 1589-1602
14 p.
 artikel
103 γ-Secretase inhibitors and Alzheimer’s disease Roberts, Susan B
 2002
 110-111 12 p. 1579-1588
10 p.
 artikel
104 Silk constructs for delivery of musculoskeletal therapeutics Meinel, Lorenz
 2012
 110-111 12 p. 1111-1122
12 p.
 artikel
105 Stem cell gene manipulation and delivery as systemic therapeutics Almeida-Porada, Graça D.
 2010
 110-111 12 p. 1139-1140
2 p.
 artikel
106 Strategies for controlled delivery of growth factors and cells for bone regeneration Vo, Tiffany N.
 2012
 110-111 12 p. 1292-1309
18 p.
 artikel
107 Studies of bone morphogenetic protein-based surgical repair Lo, Kevin W.-H.
 2012
 110-111 12 p. 1277-1291
15 p.
 artikel
108 Surface-functionalized electrospun nanofibers for tissue engineering and drug delivery Yoo, Hyuk Sang
 2009
 110-111 12 p. 1033-1042
10 p.
 artikel
109 Surface plasmon resonance in monitoring of complement activation on biomaterials Arima, Yusuke
 2011
 110-111 12 p. 988-999
12 p.
 artikel
110 Synthetic strategies for the generation of molecularly imprinted organic polymers Mayes, A.G.
 2005
 110-111 12 p. 1742-1778
37 p.
 artikel
111 Targeted delivery of therapeutics to bone and connective tissues Grainger, David W.
 2012
 110-111 12 p. 1061-1062
2 p.
 artikel
112 Targeting polymer therapeutics to bone Low, Stewart A.
 2012
 110-111 12 p. 1189-1204
16 p.
 artikel
113 The application of nanofibrous scaffolds in neural tissue engineering Cao, Haoqing
 2009
 110-111 12 p. 1055-1064
10 p.
 artikel
114 The chemistry of irreversible capture Meares, Claude F.
 2008
 110-111 12 p. 1383-1388
6 p.
 artikel
115 Therapeutic application of RNA interference for hepatitis C virus Watanabe, Tsunamasa
 2007
 110-111 12 p. 1263-1276
14 p.
 artikel
116 The structure of the choroid plexus and the physiology of the choroid plexus epithelium Redzic, Zoran B.
 2004
 110-111 12 p. 1695-1716
22 p.
 artikel
117 The Wnt signaling pathway in cellular proliferation and differentiation: A tale of two coactivators Teo, Jia-Ling
 2010
 110-111 12 p. 1149-1155
7 p.
 artikel
118 Toward evidence based control of hepatitis C virus infection Miyamura, Tatsuo
 2007
 110-111 12 p. 1195-
1 p.
 artikel
119 Usefulness and limitation of primary cultured porcine choroid plexus epithelial cells as an in vitro model to study drug transport at the blood–CSF barrier Angelow, Susanne
 2004
 110-111 12 p. 1859-1873
15 p.
 artikel
120 Use of antibodies and immunoconjugates for the therapy of more accessible cancers Sharkey, Robert M.
 2008
 110-111 12 p. 1407-1420
14 p.
 artikel
121 Use of neuroimaging to detect early brain changes in people at genetic risk for Alzheimer’s disease Small, Gary W
 2002
 110-111 12 p. 1561-1566
6 p.
 artikel
122 Vascular disorder in Alzheimer’s disease: role in pathogenesis of dementia and therapeutic targets Zlokovic, Berislav V
 2002
 110-111 12 p. 1553-1559
7 p.
 artikel
                             122 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland